X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11552) 11552
Publication (1369) 1369
Book Review (147) 147
Book Chapter (36) 36
Conference Proceeding (8) 8
Book / eBook (6) 6
Newsletter (3) 3
Dissertation (2) 2
Magazine Article (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8405) 8405
animals (4945) 4945
index medicus (4016) 4016
male (3605) 3605
female (3526) 3526
mice (2169) 2169
plasminogen activator inhibitor 1 - metabolism (1933) 1933
middle aged (1889) 1889
plasminogen-activator (1818) 1818
adult (1694) 1694
cells, cultured (1578) 1578
biochemistry & molecular biology (1575) 1575
expression (1527) 1527
urokinase-type plasminogen activator - metabolism (1502) 1502
hematology (1493) 1493
fibrinolysis (1425) 1425
peripheral vascular disease (1352) 1352
plasminogen-activator inhibitor-1 (1306) 1306
rats (1305) 1305
plasminogen activator inhibitor 1 - genetics (1279) 1279
aged (1227) 1227
cell biology (1216) 1216
oncology (1127) 1127
tissue plasminogen activator - metabolism (997) 997
endocrinology & metabolism (994) 994
plasminogen activator inhibitor 1 - blood (991) 991
research (928) 928
risk factors (871) 871
proteins (814) 814
inflammation (791) 791
rna, messenger - metabolism (790) 790
gene expression (761) 761
urokinase (749) 749
time factors (736) 736
research article (716) 716
endothelial-cells (714) 714
cell line, tumor (713) 713
pai-1 (712) 712
cancer (701) 701
gene-expression (692) 692
signal transduction (663) 663
cell line (648) 648
physiological aspects (643) 643
plasminogen - metabolism (642) 642
article (634) 634
analysis (629) 629
cells (629) 629
mice, inbred c57bl (623) 623
plasminogen activators - metabolism (618) 618
metastasis (617) 617
myocardial-infarction (603) 603
tissue plasminogen activator (591) 591
kinetics (587) 587
urokinase-type plasminogen activator - genetics (586) 586
in-vitro (585) 585
immunohistochemistry (581) 581
disease models, animal (577) 577
dose-response relationship, drug (564) 564
medicine (558) 558
in-vivo (554) 554
angiogenesis (552) 552
plasminogen-activator inhibitor (552) 552
invasion (544) 544
molecular sequence data (544) 544
pharmacology & pharmacy (543) 543
tumor cells, cultured (543) 543
multidisciplinary sciences (541) 541
receptors, urokinase plasminogen activator (541) 541
medicine, research & experimental (523) 523
physiology (522) 522
apoptosis (521) 521
neurosciences (515) 515
receptor (512) 512
health aspects (510) 510
matrix metalloproteinases (510) 510
enzyme-linked immunosorbent assay (506) 506
blotting, western (505) 505
protein binding (501) 501
plasma (490) 490
rna, messenger - genetics (489) 489
messenger-rna (483) 483
atherosclerosis (480) 480
endothelium, vascular - metabolism (480) 480
thrombosis (480) 480
fibrinolysin - metabolism (478) 478
extracellular-matrix (477) 477
coagulation (475) 475
plasminogen activator inhibitor-1 (471) 471
reverse transcriptase polymerase chain reaction (464) 464
neoplasm invasiveness (459) 459
system (453) 453
receptors, cell surface - metabolism (441) 441
fibrinolysis - drug effects (440) 440
obesity (440) 440
amino acid sequence (437) 437
insulin-resistance (436) 436
plasminogen activator inhibitor 1 - biosynthesis (433) 433
fibrinogen - metabolism (430) 430
disease (426) 426
rats, sprague-dawley (425) 425
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11442) 11442
Chinese (54) 54
Japanese (24) 24
Russian (15) 15
Polish (13) 13
German (11) 11
French (8) 8
Korean (4) 4
Slovak (4) 4
Spanish (3) 3
Hungarian (2) 2
Serbian (2) 2
Turkish (2) 2
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Aging Cell, ISSN 1474-9718, 08/2015, Volume 14, Issue 4, pp. 644 - 658
The healthspan of mice is enhanced by killing senescent cells using a transgenic suicide gene. Achieving the same using small molecules would have a tremendous... 
dasatinib | plasminogen‐activated inhibitor | dependence receptors | quercetin | ephrins | 3K delta | p21 | Dasatinib | Dependence receptors | Ephrins | Plasminogen-activated inhibitor | Quercetin | PI3K delta | P21 | ENDOTHELIAL DYSFUNCTION | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | EXPRESSION PROFILES | plasminogen-activated inhibitor | CELLULAR SENESCENCE | CANCER-THERAPY | CELL BIOLOGY | GERIATRICS & GERONTOLOGY | LUNG-CANCER | SET ENRICHMENT ANALYSIS | GENE-EXPRESSION | IONIZING-RADIATION | TUMOR-GROWTH | Carotid Arteries - drug effects | Endonucleases - genetics | Plasminogen Activator Inhibitor 2 - genetics | Transcriptome | Gene Expression Profiling | Adipocytes - drug effects | Aging - genetics | Osteoporosis - metabolism | Ephrins - metabolism | Plasminogen Activator Inhibitor 2 - metabolism | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Osteoporosis - genetics | Intervertebral Disc - pathology | Fibroblasts - metabolism | Endothelial Cells - metabolism | Intervertebral Disc - chemistry | Fibroblasts - pathology | Mesenchymal Stem Cells - pathology | Mice, Knockout | Dasatinib - pharmacology | Osteoporosis - pathology | Ephrins - genetics | Fibroblasts - drug effects | Mice | Endothelial Cells - pathology | bcl-X Protein - metabolism | Aging - metabolism | Aging - drug effects | bcl-X Protein - genetics | Cellular Senescence - drug effects | Phosphatidylinositol 3-Kinases - metabolism | Endonucleases - metabolism | DNA-Binding Proteins - metabolism | Cyclin-Dependent Kinase Inhibitor p21 - genetics | Mesenchymal Stem Cells - drug effects | Mesenchymal Stem Cells - metabolism | Heart - physiopathology | Cellular Senescence - genetics | Osteoporosis - prevention & control | DNA-Binding Proteins - genetics | Adipocytes - pathology | Aging - pathology | Phosphatidylinositol 3-Kinases - genetics | Animals | Quercetin - pharmacology | Adipocytes - metabolism | Heart - drug effects | Carotid Arteries - pathology | Intervertebral Disc - drug effects | Drug Combinations | Endothelial Cells - drug effects | Original
Journal Article
Journal Article
The Journal of Immunology, ISSN 0022-1767, 03/2010, Volume 184, Issue 5, pp. 2663 - 2670
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2013, Volume 110, Issue 40, pp. 16079 - 16084
Journal Article
Biochemical Journal, ISSN 0264-6021, 12/2007, Volume 408, Issue 2, pp. 203 - 210
PAI-I and PAI-2 (plasminogen-activator inhibitor types I and 2) are inhibitors of cell surface upA (urokinase plasminogen activator). However, tumour... 
Serpin (serine protease inhibitor) | Plasminogen-activator inhibitor type 2 (PAI-2) | Urokinase plasminogen activator (uPA) | Very-low-density lipoprotein receptor (VLDLr) | Plasminogen-activator inhibitor type 1 (PAI-1) | SYSTEM | very-low-density lipoprotein receptor (VLDLr) | PROTEIN | LDL RECEPTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | plasminogen-activator inhibitor type 1 (PAI-1) | serpin (serine protease inhibitor) | urokinase plasminogen activator (uPA) | COMPLEX-FORMATION | RAP COMPLEX | plasminogen-activator inhibitor type 2 (PAI-2) | DENSITY-LIPOPROTEIN-RECEPTOR | UROKINASE RECEPTOR | BINDING-SITE | LIGAND | Humans | Receptors, Cell Surface - metabolism | Receptors, LDL - metabolism | Plasminogen Activator Inhibitor 2 - physiology | Plasminogen Activator Inhibitor 1 - physiology | Breast Neoplasms - metabolism | Receptors, Urokinase Plasminogen Activator | Breast Neoplasms - chemistry | Plasminogen Activator Inhibitor 1 - chemistry | Plasminogen Activator Inhibitor 1 - metabolism | Urokinase-Type Plasminogen Activator - metabolism | Breast Neoplasms - pathology | Plasminogen Activator Inhibitor 2 - metabolism | Protein Structure, Secondary - physiology | Signal Transduction - physiology | Urokinase-Type Plasminogen Activator - chemistry | Tumor Cells, Cultured | Plasminogen Activator Inhibitor 2 - chemistry | Protein Binding - physiology | Protein Structure, Tertiary - physiology | uPA, urokinase plasminogen activator | LDLR, low-density lipoprotein receptor | serpin, serine protease inhibitor | uPAR, urokinase plasminogen activator receptor | VLDLr, very-low-density lipoprotein receptor | PAI, plasminogen-activator inhibitor | RAP, receptor-associated protein | RCL, reactive centre loop | ERK, extracellular-signal-regulated kinase | plasminogen-activator inhibitor type 1 (PAI-1) | LRP, low-density lipoprotein receptor-related protein | SPR, surface plasmon resonance | plasminogen-activator inhibitor type 2 (PAI-2)
Journal Article
Journal Article
Cellular and Molecular Life Sciences, ISSN 1420-682X, 10/1999, Volume 56, Issue 1, pp. 104 - 132
The regulation of plasminogen activation involves genes for two plasminogen activators (tissue type and urokinase type), two specific inhibitors (type 1 and... 
cell motility | fibrinolysis | Cell invasion | metastasis | signal transduction | transcriptional regulation | plasminogen activator | plasminogen activator inhibitor | uPA receptor | mRNA stability | Cell motility | Signal transduction | Plasminogen activator | Metastasis | Plasminogen activator inhibitor | Transcriptional regulation | Fibrinolysis | 3' UNTRANSLATED REGION | PROTEIN-KINASE-C | RECEPTOR-BOUND UROKINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | INHIBITOR TYPE-2 GENE | HUMAN-ENDOTHELIAL-CELLS | CAMP-RESPONSIVE ELEMENT | MESSENGER-RNA STABILITY | CELL BIOLOGY | TUMOR-NECROSIS-FACTOR | GROWTH-FACTOR-BETA | PHORBOL-MYRISTATE-ACETATE | cell invasion | Plasminogen Activator Inhibitor 2 - genetics | Signal Transduction | Humans | Gene Expression Regulation | Receptors, Cell Surface - metabolism | Plasminogen - metabolism | Urokinase-Type Plasminogen Activator - genetics | RNA, Messenger - metabolism | Receptors, Urokinase Plasminogen Activator | Plasminogen Activators - physiology | Animals | Plasminogen Activator Inhibitor 1 - metabolism | Urokinase-Type Plasminogen Activator - metabolism | Plasminogen Activator Inhibitor 2 - metabolism | Plasminogen Activator Inhibitor 1 - genetics | Plasminogen Activators - genetics | Receptors, Cell Surface - genetics | Thrombolytic drugs | Proteins | Cellular biology | Gene expression | Cell adhesion & migration
Journal Article